BYSI - Company ID 0001677940
BeyondSpring Inc. trades as BYSI. In its fiscal 2025 annual report the company posted revenue of $0.00 and net income of -$1.01M. This page tracks BeyondSpring Inc. through 245 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Net profit margin expanded from -33873.9% to -2463.3% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-13 |
| Major company event | 8-K | 2026-05-13 |
| Insider trade | 4 | 2026-04-08 |
| Insider trade | 4 | 2026-04-03 |
| Insider trade | 4 | 2026-04-03 |
| Insider trade | 4 | 2026-04-03 |
The largest companies sharing BeyondSpring Inc.'s SEC industry classification (pharmaceutical preparations).
BeyondSpring Inc. reported revenue of $0.00 for fiscal year 2025.
In its latest fiscal year BeyondSpring Inc. reported a net loss of $1.01M.